Atrial and Brain Natriuretic Peptide and Endothelin-1 Concentration in Patients with Idiopathic Arterial Hypertension: The Dependence on the Selected Morphological Parameters

References

• Kannel WB, Cobb J. Left ventricular hypertrophy and mortality—results from the Framingham Study. Cardiology. 1992; 81: 291–297
   PubMed Web of Science ®Google Scholar
• Devereux RB, Roman MJ, Ganau A, et al. Cardiac and arterial hypertrophy and atherosclerosis in hypertension. Hypertension. 1994; 23(Part I)802–809
   PubMedGoogle Scholar
• de Simone G, Roman MJ, Koren MJ, et al. Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension. Hypertension. 1999; 33: 800–805
   PubMed Web of Science ®Google Scholar
• Galderisi M, Petrocelli A, Alfieri A, et al. Impact of ambulatory blood pressure on left ventricular diastolic dysfunction in uncomplicated arterial systemic hypertension. Am J Cardiol. 1996; 77: 597–601
   PubMed Web of Science ®Google Scholar
• Levy D, Savage DD, Garrison RJ, et al. Echocardiographic criteria for left ventricular hypertrophy. The Framingham Heart Study. Am J Cardiol. 1987; 59: 956–960
   PubMed Web of Science ®Google Scholar
• Chen HH, Burnett JC. Natriuretic peptides in the pathophysiology of congestive heart failure. Curr Cardiol Rep. 2000; 2(3)198–205
   PubMedGoogle Scholar
• Detaint D, Messika-Zeitoun D, Avierinos JF, et al. B-type natriuretic peptide in organic mitral regurgitation. Determinants and impact on outcome. Circulation. 2005; 111: 2391–2397
   PubMed Web of Science ®Google Scholar
• Semplicini A, Ceolotto G, Sartor M, et al. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide. J Nephrol. 2002; 15(5)489–496
   PubMed Web of Science ®Google Scholar
• Mussalo H, Vanninen E, Ikäheimo R, et al. NT-proANP and BNP in renovascular and in severe and mild essential hypertension. Kidney & Blood Pres Res. 2003; 26: 34–41
   PubMed Web of Science ®Google Scholar
• Banach M, Markuszewski L, Zaslonka J, et al. The role of inflammation in the pathogenesis of atherosclerosis. Przegl Epidemiol. 2004; 58(4)663–670
   PubMedGoogle Scholar
• Banach M, Drożdż J, Okonski P, Rysz J. Immunological aspects of the statins' function in patients with heart failure. Cell Mol Immunol. 2005; 2(6)433–437
   PubMed Web of Science ®Google Scholar
• Pokharel D, Sharma UC, Pinto YM. Left ventricular hypertrophy: vitreous intentions, malign consequences. Int J Bioch Cell. 2003; 35: 802–806
   PubMed Web of Science ®Google Scholar
• Chobaniam AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA. 2003; 289: 2560–2572
   PubMed Web of Science ®Google Scholar
• Devereux RB. Regression of left ventricular hypertrophy. How and why?. JAMA. 1996; 275: 1517–1518
   PubMed Web of Science ®Google Scholar
• Shimizu G, Zile MR, Blaustein AS, Gaasch WH. Left ventricular chamber filling and midwall fiber lengthening in patients with left ventricular hypertrophy: Overestimation of fiber velocities by conventional midwall measurements. Circulation. 1985; 71: 266–272
   PubMed Web of Science ®Google Scholar
• Mayet J, Ariff B, Wasan B, et al. Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy. Hypertension. 2000; 36: 755–761
   PubMed Web of Science ®Google Scholar
• Li L, Shigematsu Y, Hamada M, Hidawa K. Relative wall thickness is an independent predictor of left ventricular systolic and diastolic dysfunctions in essential hypertension. Hypertens Res. 2001; 24(5)439–499
   Google Scholar
• de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci. 1981; 28: 89–94
   PubMed Web of Science ®Google Scholar
• Nagy V. Left ventricular hypertrophy: pathogenesis, diagnosis and therapy. Orv Hetil. 2001; 142(26)1375–1383
   PubMedGoogle Scholar
• Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J. 1991; 5: 3037–3046
   PubMed Web of Science ®Google Scholar
• McKinsey TA, Nolson EN. Cardiac hypertrophy: sorting out the circuitry. Curr Opin Genet Dev. 1999; 9: 267–274
   PubMed Web of Science ®Google Scholar
• Muscholl MW, Schunkert H, Muders F, et al. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension. Am Heart J. 1998; 135(1)58–66
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Yoshitaka H, Masakatsu O, Yoshiki S, et al. Left atrial diameter is a simple indicator of a deficiency in atrial natriuretic peptide secretion in patients with mitral stenosis: efficacy of postoperative supplementation with synthetic human (alpha)-atrial natriuretic peptide. J Cardiovasc Pharmacol. 2004; 44(6)709–717
   PubMed Web of Science ®Google Scholar
• Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988; 332: 78–81
   PubMed Web of Science ®Google Scholar
• McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly Multinational Study. Circulation. 2002; 106: 416–422
   PubMed Web of Science ®Google Scholar
• Magga J, Puhakka M, Hietakorpi S, et al. Atrial natriuretic peptide, B-type natriuretic peptide, and serum collagen markers after acute myocardial infarction. J Appl Physiol. 2004; 96: 1306–1311
   PubMed Web of Science ®Google Scholar
• Tapanainen JM, Lindgren KS, Mäkikallio TH, et al. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol. 2004; 43: 757–763
   PubMed Web of Science ®Google Scholar
• Wright GA, Struthers AD. Natriuretic peptides as a prognostic marker and therapeutic target in heart failure. Heart. 2006; 92: 149–151
   PubMed Web of Science ®Google Scholar
• Bettencourt P, Ferreira A, Sousa T, et al. Brain natriuretic peptide as a marker of cardiac involvement in hypertension. Int J Cardiol. 1999; 69: 169–177
   PubMed Web of Science ®Google Scholar
• Nakamura M, Tanaka F, Yonezawa S, et al. The limited value of plasma B-type natriuretic peptide for screening for left ventricular hypertrophy among hypertensive patients. Am J Hypertens. 2003; 16: 1025–1029
   PubMed Web of Science ®Google Scholar
• Mayett J, Ariff B, Wasan B, et al. Midwall myocardial shortening in athletic left ventricular hypertrophy. Int J Cardiol. 2002; 86(2–3)233–238
   PubMed Web of Science ®Google Scholar
• Irzmański R, Banach M, Piechota M, et al. BNP concentration in patients with mitral stenosis. Dependence on selected morphological parameters. Arch Med Sci. 2006; 2(3)159–163
   Google Scholar
• Schiffrinn EL, Thibault G. Plasma endothelin in essential hypertension. Am J Hypertens. 1991; 4: 303–308
   PubMed Web of Science ®Google Scholar
• Schneider MP, Hilgers KF, Klingbeil AU, et al. Plasma endothelin is increased in early essential hypertension. Am J Hypertens. 2000; 13: 579–585
   PubMed Web of Science ®Google Scholar
• Taddei S, Virdis A, Ghiadoni L, et al. Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension. Circulation. 1999; 100: 1680–1683
   PubMed Web of Science ®Google Scholar
• Hua L, Li C, Xia D, et al. Relationship between hypertensive left ventricular hypertrophy and levels of endothelin and nitric oxide. Hypertens Res. 2000; 23(4)377–380
   PubMed Web of Science ®Google Scholar
• Nohria A, Garrett L, Johnson W, et al. Endothelin-1 and vascular tone in subjects with atherogenic risk factors. Hypertension. 2003; 42: 43–48
   PubMed Web of Science ®Google Scholar
• Irzmański R, Piechota M, Kowalski J, et al. Dynamics of changes of endothelin concentration and its relation to left ventricular mass in patients subjected to planned percutaneous transluminal coronary angioplasty. Folia Cardiol. 2005; 12(11)734–739
   Google Scholar
• Schunkert H, Orzechowski HD, Bocker W, et al. The cardiac endothelin system in established pressure overload left ventricular hypertrophy. J Mol Med. 1999; 77(8)623–630
   PubMed Web of Science ®Google Scholar
• Brown DW, Giles WH, Croft JB. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am Heart J. 2000; 140: 848–856
   PubMed Web of Science ®Google Scholar